Human medicines European public assessment report (EPAR): Jyseleca, filgotinib, Arthritis, Rheumatoid, Date of authorisation: 24/09/2020, Revision: 1, Status: Authorised

SEMrush
Human medicines European public assessment report (EPAR): Jyseleca, filgotinib, Arthritis, Rheumatoid, Date of authorisation: 24/09/2020, Revision: 1, Status: Authorised
[automaticbacklinks]